{ "Monitoring Atrial Fibrillation Recurrence with BodyGuardian", "This study, called BOUNCE-AF, is looking at how well a device called BodyGuardian can monitor for atrial fibrillation (AF) recurrence after a procedure. Atrial fibrillation is an irregular heartbeat. You might be able to join if you are already participating in another study called DISRUPT-AF, which is looking at the FARAPULSE Pulsed Field Ablation (PFA) System for AF treatment. If you join BOUNCE-AF, you would wear the BodyGuardian device for six months after your ablation procedure. The main goal is to see how well the BodyGuardian monitors for AF recurrence during this time. This study is observational, meaning researchers will collect information without giving you a specific treatment.", "design": "This is an observational study with a planned enrollment of 100 participants. It is not randomized, meaning participants are not assigned to different groups by chance.", "commitments": "You would wear the BodyGuardian device for six months after your ablation procedure. You will also complete one survey about your experience after wearing the BodyGuardian at 6 months.", "compensation": "Not stated in the trial record.", "follow_up": "Participants will be monitored from enrollment until the end of BodyGuardian wear at 6 months. Post-ablation monitoring timepoints typically reflect standard of care, which is often at 6 and 12 months.", }

Study design

Not specified.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.